Inhalation Therapies for Lung Diseases

    HOME > Our Company > Inhalation Therapies for Lung Diseases

Inhalation Therapies for Lung Diseases

Lung Diseases

Inhalation Therapies for Lung Diseases there are a number of common lung diseases which can be treated with inhaled therapies. For instance, both asthma and chronic obstructive pulmonary disease (COPD) have several inhaled treatment options available to help manage the conditions. Inhaled treatment options are available in a number of different drug-device combinations. These include dry powder inhalers (DPIs), pressurized-metered dose inhalers (pMDIs) or soft mist inhalers (SMIs) containing a short-acting beta-2 agonist (SABA), long acting beta-2 agonist (LABA), inhaled corticosteroid (ICS), or long acting muscarinic antagonist (LAMA) as mono therapies or combination therapies of ICS-LABA, LABA-LAMA, or ICS-LABA-LAMA. These and similar medicines have been proven safe and effective for the treatment of asthma and/or COPD, and are widely used.

Unfortunately, these medicines are costly to develop and can be expensive to purchase, which limits the broader use of these essential therapeutics. At Transpire Bio we believe that all patients suffering from these diseases should have access to affordable inhaled therapeutics. This is why we are dedicated to developing and bringing to the market lower-cost, high-quality generic alternatives across all inhaler types.